CD44 mRNA expression was induced following chronic exposure to 300 μM DETANO (Figure 5A) and is consistent with induced expression in high NOS2 expressing ER- breast tumors and NO-induced CD44 protein expression in TNBC breast cancer cells [7,14]. The gene discussed is CD44; the disease is breast carcinoma.